Skip to content

DR. BEUTELS MICHEL

Active Private limited companyfounded 2001active for 25 yearsLariksdreef 36, 2900 SchotenKBO/BCE: BE 0475.919.315

Lifetime

24 annual accounts with figures on one time axis
peak of €277,124 in 2013
€83,430▼ 58.2%
lowest -€68,546 in 2016
€57,364▼ 55.3%
peak of €746,631 in 2020
€468,279▼ 19.2%
€87,466▼ 36.7%
peak of 0.7 FTE in 2010
0 FTE 
Board1 name since 2001
1 director
Documentsfilings and deeds
05-11-202697 days late
2025abbreviated format
Gross margin from €199,564 to €83,430Result from €128,278 to €57,364Dividend €168,517Equity from €579,432 to €468,279Debts from €138,107 to €87,466Cash from €61,394 to €158,199

Key points

from the 2025 annual accounts

Equity

€468,279 ▼ 19.2%
579,4322024+57,364Profit-168,517Dividend468,2792025

DR. BEUTELS MICHEL paid out €168,517 in dividends. That is 294% of the 2025 profit.

Result

€57,364 ▼ 55.3%
€128,0002024€57,4002025

The result fell in 2025 from €128,278 to €57,364.

Filings

24 annual accounts 97 days
AprilJune31 JulyOctober20102020

Latest accounts filed late: after the legal deadline.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,148 companies had the same profile as DR. BEUTELS MICHEL has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,148 companies, not a prediction for DR. BEUTELS MICHEL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 19-10-2001

Shares in 1 company,

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0475919315
appointed as director Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 08-12-2023 · Gazette deed
Incorporation published on 06-11-2001 · Gazette deed
First establishment Laarsebaan 322, Antwerp
All 35 events

Comparable companies

same main activity, similar in size and age
Company
DR. BEUTELS MICHEL Schoten €555,745 €83,430 84.3% 0
DR. PH. ALBERTYN Aartselaar €560,490 €85,919 39.8% 0
DOKTER WALTER PENDERS Lebbeke €659,165 €89,580 87.5% 0.3
BIJVENNE PROPERTIES Hasselt €875,106 €81,116 79.4% 0
DABIGA MEDICALE Grâce-Hollogne €465,539 €93,447 73.8% 0.6
Dr. Deldime Luc Wortegem-Petegem €907,583 €84,079 63.1% 0.3
Dr. Canizares Peres Ana Cristina Overijse €500,159 €123,986 94.4% 0

These companies have the same main activity as DR. BEUTELS MICHEL: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €466,000 and €908,000, founded between 1998 and 2008.

Official details

Source: KBO
Status
Active since 23-10-2001Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.228.986.0612170 Antwerp, since 19-10-2001
Financial year end
31 December
Peppol
Reachable since 13-10-2025
Company details

Annual accounts 2025

≈ €200,000estimated
€555,745▼ 22.5%
Filing
Filed on 05-11-2026
Financials

Insights on DR. BEUTELS MICHEL

DR. BEUTELS MICHEL files the abbreviated format. That format states no turnover. The gross margin fell from €116,966 in 2002 to €83,430 in 2025.

The balance sheet grew most from 2004 to 2006 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. BEUTELS MICHEL

What is the company number of DR. BEUTELS MICHEL?
The company number of DR. BEUTELS MICHEL is 0475.919.315. The VAT number is the same number with BE in front: BE 0475.919.315.
Where is DR. BEUTELS MICHEL based?
The registered office is at Lariksdreef 36, 2900 Schoten.Company details
What does DR. BEUTELS MICHEL do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. BEUTELS MICHEL?
DR. BEUTELS MICHEL is a private limited company (BV).
When was DR. BEUTELS MICHEL founded?
DR. BEUTELS MICHEL was founded on 23-10-2001.
Is DR. BEUTELS MICHEL still active?
Yes, DR. BEUTELS MICHEL is an active enterprise in the KBO register.
What is the turnover of DR. BEUTELS MICHEL?
The turnover in financial year 2025 is about €200,000. This figure is estimated from the gross margin of €83,430 and 46 comparable companies (NACE 862). It probably lies between €150,000 and €310,000.Financials
Is DR. BEUTELS MICHEL profitable?
In financial year 2025, DR. BEUTELS MICHEL made a profit of €57,364.
Where can I find the annual accounts of DR. BEUTELS MICHEL?
DR. BEUTELS MICHEL filed 24 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. BEUTELS MICHEL due?
DR. BEUTELS MICHEL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.